Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 1
2004 1
2006 1
2008 1
2010 3
2012 1
2013 2
2014 1
2015 2
2020 1
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
Morokutti-Kurz M, Fröba M, Graf P, Große M, Grassauer A, Auth J, Schubert U, Prieschl-Grassauer E. Morokutti-Kurz M, et al. Among authors: grassauer a. PLoS One. 2021 Feb 17;16(2):e0237480. doi: 10.1371/journal.pone.0237480. eCollection 2021. PLoS One. 2021. PMID: 33596218 Free PMC article.
Non-clinical safety evaluation of intranasal iota-carrageenan.
Hebar A, Koller C, Seifert JM, Chabicovsky M, Bodenteich A, Bernkop-Schnürch A, Grassauer A, Prieschl-Grassauer E. Hebar A, et al. Among authors: grassauer a. PLoS One. 2015 Apr 13;10(4):e0122911. doi: 10.1371/journal.pone.0122911. eCollection 2015. PLoS One. 2015. PMID: 25875737 Free PMC article.
Saponin Micelles Lead to High Mucosal Permeation and In Vivo Efficacy of Solubilized Budesonide.
Nakowitsch S, Koller C, Seifert JM, König-Schuster M, Unger-Manhart N, Siegl C, Kirchoff N, Foglar E, Graf C, Morokutti-Kurz M, Neurath M, Sladek S, Knecht C, Sipos W, Prieschl-Grassauer E, Grassauer A. Nakowitsch S, et al. Among authors: grassauer a. Pharmaceutics. 2020 Sep 5;12(9):847. doi: 10.3390/pharmaceutics12090847. Pharmaceutics. 2020. PMID: 32899549 Free PMC article.
Iota-carrageenan is a potent inhibitor of influenza A virus infection.
Leibbrandt A, Meier C, König-Schuster M, Weinmüllner R, Kalthoff D, Pflugfelder B, Graf P, Frank-Gehrke B, Beer M, Fazekas T, Unger H, Prieschl-Grassauer E, Grassauer A. Leibbrandt A, et al. Among authors: grassauer a. PLoS One. 2010 Dec 14;5(12):e14320. doi: 10.1371/journal.pone.0014320. PLoS One. 2010. PMID: 21179403 Free PMC article.
The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model.
Morokutti-Kurz M, König-Schuster M, Koller C, Graf C, Graf P, Kirchoff N, Reutterer B, Seifert JM, Unger H, Grassauer A, Prieschl-Grassauer E, Nakowitsch S. Morokutti-Kurz M, et al. Among authors: grassauer a. PLoS One. 2015 Jun 8;10(6):e0128794. doi: 10.1371/journal.pone.0128794. eCollection 2015. PLoS One. 2015. PMID: 26053018 Free PMC article.
The Saliva of Probands Sucking an Iota-Carrageenan Containing Lozenge Inhibits Viral Binding and Replication of the Most Predominant Common Cold Viruses and SARS-CoV-2.
Morokutti-Kurz M, Unger-Manhart N, Graf P, Rauch P, Kodnar J, Große M, Setz C, Savli M, Ehrenreich F, Grassauer A, Prieschl-Grassauer E, Schubert U. Morokutti-Kurz M, et al. Among authors: grassauer a. Int J Gen Med. 2021 Sep 7;14:5241-5249. doi: 10.2147/IJGM.S325861. eCollection 2021. Int J Gen Med. 2021. PMID: 34526804 Free PMC article. Clinical Trial.
19 results